Theranostic radioiodine-labelled melanin nanoparticles inspired by clinical brachytherapy seeds
Theranostic radioiodine-labelled melanin nanoparticles inspired by clinical brachytherapy seeds
复制标题
受临床近距离放射治疗种子启发的治疗诊断放射性碘标记黑色素纳米颗粒
DOI:
10.1039/c8tb02817f
复制
发表时间:
2018
影响因子:
7
通讯作者:
Yang Min
中科院分区:
文献类型:
--
作者:
Sheng Jie;Wang Xinyu;Yan Junjie;Pan Donghui;Yang Runlin;Wang Lizhen;Xu Yuping;Yang Min
Radioiodine is widely used in nuclear medicine, mainly serving as a tracer and therapeutic agent, and benefits from its various radioactive isotopes of iodine including I-123, I-124, I-125, I-131 and so on. Melanin is a natural material widely dispersed in the human skin, hair and eyes. The excellent biocompatibility and multifunctional abilities of melanin make it a perfect carrier for biomedical applications. Here, we fabricated theranostic radioiodine-labelled melanin nanoparticles (MNPs) through a novel Ag–I two-step method. The Ag–I labelling method for MNP radioiodine-labelling has advantages including a faster labelling time, higher labelling yield, and higher stability than the chloramine-T oxidation method reported previously. The obtained MNP–Ag–131I can be used for both single-photon emission computed tomography and Cherenkov radiation imaging. The β-rays of 131I also make it a good candidate as a cancer cell killer. The theranostic properties of this nanoparticle were also proved in a xenograft tumor model in vivo. In summary, this study provides a new concept for radioiodine labelling nanoparticles, which can be further investigated in various imaging and radiotherapy applications with different radioactive isotopes of iodine.